The Glomerular Filtration Rate (GFR), how it is measured, and the estimated glomerular filtration rate (eGFR)
The glomerular filtration rate (GFR) is a key measure of kidney function that indicates how effectively the kidneys are filtering waste products and excess fluids from the blood. Specifically, GFR estimates the volume of blood filtered by the glomeruli—the tiny filtering units within the kidneys—per minute. Maintaining a normal GFR is essential for removing toxins and maintaining fluid and electrolyte balance in the body.
.jpg)
Table of Contents
What is Glomerular Filtration Rate (GFR)?
The kidneys play a vital role in maintaining the body's internal balance, or homeostasis, by filtering blood to remove waste products, excess electrolytes, and water. These filtered substances are then excreted as urine. This critical filtration process occurs in the glomeruli, which are tiny networks of capillaries located within the nephrons—the functional units of the kidney responsible for producing urine.
The glomerular filtration rate (GFR) is a quantitative measure of how much blood is filtered by the glomeruli each minute. Essentially, it reflects the efficiency and health of the kidneys’ filtering capacity. Because the kidneys filter a large volume of blood daily, maintaining an adequate GFR is essential for removing toxins, regulating fluid and electrolyte balance, and sustaining overall metabolic stability.
A normal GFR in a healthy adult generally ranges between 90 to 120 mL/min/1.73 m², adjusted for body surface area, with variations influenced by factors such as age, sex, ethnicity, and body size. For example, GFR naturally decreases with aging, often declining by approximately 1 mL/min per year after age 40. Despite this natural decline, a significant or rapid reduction in GFR is a red flag, often indicating impaired kidney function or underlying kidney disease.
Monitoring GFR is critical because a sustained low GFR can lead to the accumulation of waste products and fluid imbalances in the body, which may result in symptoms like fatigue, swelling, and complications such as hypertension and electrolyte disturbances. GFR measurement also helps classify the stages of chronic kidney disease (CKD), guiding treatment decisions and the need for interventions such as dialysis or kidney transplantation.
Values of Glomerular Filtration Rate (GFR)
The glomerular filtration rate (GFR) is measured in milliliters per minute per 1.73 square meters (mL/min/1.73 m²), which standardizes the value to a typical adult body surface area. This normalization allows comparison between individuals of different sizes.
The normal GFR range in healthy adults is generally considered to be between 90 and 120 mL/min/1.73 m². A GFR below 60 mL/min/1.73 m² that persists for more than three months is a key criterion for diagnosing chronic kidney disease (CKD).
CKD is classified into five stages based on the GFR values, helping to guide prognosis and treatment:
Stage 1: GFR ≥ 90 mL/min/1.73 m² (Normal kidney function but with evidence of kidney damage, such as protein in the urine).
Stage 2: GFR 60-89 mL/min/1.73 m² (Mild decrease in kidney function with evidence of kidney damage).
Stage 3a: GFR 45-59 mL/min/1.73 m² (Mild to moderate decrease in kidney function).
Stage 3b: GFR 30-44 mL/min/1.73 m² (Moderate to severe decrease in kidney function).
Stage 4: GFR 15-29 mL/min/1.73 m² (Severe decrease in kidney function).
Stage 5: GFR < 15 mL/min/1.73 m² (End-stage renal disease, requiring dialysis or a kidney transplant).
It is important to recognize that GFR values can vary based on factors such as age, gender, race, muscle mass, and overall health status. For instance, GFR naturally declines with age, and some ethnic groups may have different baseline values. Therefore, GFR should always be interpreted alongside other clinical findings and laboratory tests, including serum creatinine, urine output, proteinuria, and electrolyte levels, to provide a comprehensive assessment of kidney function.
How is GFR Measured?
Direct measurement of GFR is challenging because it requires the use of special substances that are filtered by the kidneys but not reabsorbed or secreted. As a result, estimated GFR (eGFR) is commonly used in clinical practice. This estimate is derived from equations that use serum creatinine levels, a waste product generated by muscle metabolism, along with patient factors such as age, sex, body size, and ethnicity.
1. Serum Creatinine and eGFR
Serum Creatinine: Creatinine is produced at a relatively constant rate by muscle metabolism and is primarily cleared from the blood by glomerular filtration. Elevated serum creatinine indicates reduced kidney filtration function since less creatinine is removed from the blood.
eGFR Equations: The most widely used formulas for estimating GFR include:
➧ Modification of Diet in Renal Disease (MDRD) Study equation: Developed from patients with chronic kidney disease, it estimates GFR based on serum creatinine and demographic factors.
➧ Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation: A newer formula that provides more accurate GFR estimates, especially at higher levels of kidney function.
These equations adjust for variables such as age, sex, and race to improve accuracy.
2. Cystatin C
Cystatin C is a low molecular weight protein produced by all nucleated cells and filtered exclusively by the kidneys. Unlike creatinine, cystatin C levels are less affected by muscle mass, diet, or other external factors, making it a valuable alternative or complementary marker for estimating GFR.
Cystatin C-based eGFR is particularly useful in populations where creatinine-based estimates may be less reliable, such as elderly patients, those with low muscle mass, or individuals with malnutrition.
3. Direct Measurement of GFR
Exogenous Filtration Markers: Direct measurement involves injecting substances like inulin (a plant polysaccharide), or radiolabeled markers such as iothalamate or iohexol, into the bloodstream.
These markers are freely filtered by the glomeruli and neither secreted nor reabsorbed by the renal tubules. By measuring the clearance rate of these substances from plasma or urine, an accurate GFR value can be obtained.
However, this procedure is time-consuming, costly, and requires specialized equipment and expertise, which limits its use to research settings or specific clinical situations where precise GFR measurement is critical.
The Modification of Diet in Renal Disease (MDRD) Equation
The Modification of Diet in Renal Disease (MDRD) equation is one of the most commonly used formulas in clinical practice to estimate kidney function, specifically the glomerular filtration rate (GFR). It plays a critical role in diagnosing, staging, and monitoring chronic kidney disease (CKD). Developed from a study on patients with kidney disease, the MDRD equation provides an estimate of the kidneys’ ability to filter blood based on easily obtainable clinical data.
Purpose and Clinical Importance
The MDRD equation estimates the estimated glomerular filtration rate (eGFR), which reflects the volume of blood filtered by the glomeruli per minute, normalized to a standard body surface area (1.73 m²). eGFR is crucial for assessing kidney function because direct measurement of GFR is cumbersome and not routinely feasible. By using this estimate, clinicians can identify early kidney dysfunction, classify CKD into stages, and guide treatment decisions and referrals to specialists.
Variables Included in the Clinical MDRD Equation
The clinical MDRD equation incorporates four key variables:
➧ Serum Creatinine: This is a waste product generated from muscle metabolism, which is normally filtered and excreted by the kidneys. Elevated serum creatinine usually indicates reduced kidney function.
➧ Age: Kidney function naturally declines with age, so age is a critical factor in adjusting the GFR estimate.
➧ Sex: Females generally have lower muscle mass and creatinine production than males, so the equation includes a correction factor for sex.
➧ Race: The equation includes a factor for African American race, based on observed differences in average creatinine generation related to muscle mass in this population.
These variables allow the MDRD equation to tailor the GFR estimate to an individual’s demographic and physiological characteristics, improving accuracy over raw creatinine levels alone.
The MDRD Equation Formula
The most widely used form of the MDRD equation, often referred to as the 4-variable MDRD, is as follows:
GFR = 175 × (serum creatinine) −1.154 × (age) −0.203 × (0.742 if female) × (1.212 if African American) × (serum albumin) −0.207 × (blood urea nitrogen) 0.711
➧ Serum creatinine is measured in milligrams per deciliter (mg/dL).
➧ Age is in years.
➧ The output eGFR is given in milliliters per minute per 1.73 square meters (mL/min/1.73 m²), standardizing kidney function for body size.
Interpretation and Use in Clinical Practice
The MDRD-derived eGFR is interpreted to assess the stage of kidney disease:
➧ Normal or mildly decreased: eGFR ≥ 60 mL/min/1.73 m²
➧ Mild to moderate decrease: eGFR 30-59 mL/min/1.73 m² (CKD stages 3a and 3b)
➧ Severe decrease: eGFR 15-29 mL/min/1.73 m² (CKD stage 4)
➧ Kidney failure: eGFR < 15 mL/min/1.73 m² (CKD stage 5, dialysis or transplant needed)
Clinicians use these stages to guide patient management, monitor progression, and decide when to initiate interventions such as medications or referral for dialysis preparation.
Limitations and Considerations of MDRD
While the MDRD equation has been revolutionary for kidney disease management, it has some important limitations:
➧ It tends to underestimate GFR in patients with normal or near-normal kidney function (>60 mL/min/1.73 m²), leading to potential misclassification.
➧ The equation is less accurate in individuals with extremes of body size, such as very muscular or very frail patients.
➧ It was primarily developed in a population of patients with CKD, so it may not perform as well in healthy populations.
➧ It requires accurate measurement of serum creatinine using standardized laboratory methods.
Because of these limitations, newer equations like the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation have been developed to provide more precise estimates across a wider range of kidney function.
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Equation
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is a widely used formula designed to estimate the glomerular filtration rate (eGFR) more accurately across a broad range of kidney function levels. Developed to address some limitations of the older MDRD equation, the CKD-EPI equation provides improved precision, especially for individuals with normal or mildly reduced kidney function. This makes it a valuable tool in both clinical practice and research for the early detection, staging, and monitoring of chronic kidney disease (CKD).
Purpose and Clinical Significance
The CKD-EPI equation estimates the estimated glomerular filtration rate (eGFR), a key indicator of kidney function that reflects how well the kidneys filter blood. Accurate estimation of GFR is essential for diagnosing CKD, evaluating its severity, and guiding treatment decisions. Unlike the MDRD equation, which tends to underestimate GFR at higher values (above 60 mL/min/1.73 m²), the CKD-EPI equation provides a more reliable eGFR across all stages of kidney function, enhancing clinical decision-making and patient care.
Variables Included in the CKD-EPI Equation
Similar to the MDRD equation, the CKD-EPI equation incorporates several important variables to tailor the eGFR estimate to the individual:
➧ Serum Creatinine: A muscle metabolism waste product filtered by the kidneys. The CKD-EPI equation uses a more complex, nonlinear relationship with creatinine to improve accuracy.
➧ Age: Kidney function typically declines with age, so age adjustments are included.
➧ Sex: Accounts for differences in creatinine production between males and females.
➧ Race: Includes a correction factor for individuals identified as Black, reflecting observed differences in average creatinine generation and filtration.
These variables help the CKD-EPI equation produce a precise estimate of kidney function adjusted for demographic and physiological differences.
The CKD-EPI Equation Formula
The CKD-EPI formula is more complex than MDRD because it uses different coefficients depending on whether serum creatinine is above or below specific thresholds, as well as different equations for males and females. The equation is typically presented as:
eGFR = 141 × min( κScr, 1) α × max( κScr, 1) −1.209 × 0.993 Age × (1.018 if female) × (1.159 if Black)
Where:
Scr = serum creatinine (mg/dL)
κ (kappa) = 0.7 for females and 0.9 for males
α (alpha) = -0.329 for females and -0.411 for males
min indicates the minimum of Scr/κ or 1
max indicates the maximum of Scr/κ or 1
Age is in years
This nuanced approach allows the equation to adjust the eGFR estimate differently depending on whether creatinine is above or below typical reference values, thereby improving accuracy.
Interpretation and Clinical Use of CKD-EPI
The eGFR calculated by the CKD-EPI equation is expressed in mL/min/1.73 m² and interpreted similarly to the MDRD eGFR:
➧ Normal or mildly decreased kidney function: eGFR ≥ 60 mL/min/1.73 m²
➧ Mild to moderate decrease: eGFR 30-59 mL/min/1.73 m² (CKD stages 3a and 3b)
➧ Severe decrease: eGFR 15-29 mL/min/1.73 m² (CKD stage 4)
➧ Kidney failure: eGFR < 15 mL/min/1.73 m² (CKD stage 5)
Because of its improved precision, CKD-EPI is increasingly preferred for clinical use and has been adopted by many laboratories and kidney disease guidelines worldwide. It allows for better risk stratification, especially in patients with near-normal kidney function, facilitating earlier diagnosis and intervention.
Advantages Over MDRD
➧ Greater accuracy at higher GFR values: CKD-EPI reduces the underestimation of kidney function seen with MDRD in individuals with eGFR > 60 mL/min/1.73 m².
➧ Improved risk prediction: Studies show CKD-EPI better predicts adverse outcomes such as progression to kidney failure and cardiovascular events.
➧ Broader applicability: It performs well across diverse populations, including healthy individuals, people with mild CKD, and those with more advanced disease.
Limitations and Considerations of CKD-EPI
Despite its improvements, the CKD-EPI equation shares some limitations common to creatinine-based eGFR calculations:
➧ Influenced by non-renal factors affecting creatinine production such as muscle mass, diet, and medications.
➧ May be less accurate in populations with unusual muscle mass, such as amputees, bodybuilders, or cachectic patients.
➧ Like MDRD, it uses race as a factor, which has sparked debate and efforts to develop race-neutral equations due to concerns about equity and biological validity.
Alternative biomarkers like cystatin C are sometimes combined with CKD-EPI creatinine equations to improve accuracy, especially when creatinine alone is unreliable.
The CKD-EPI equation represents a significant advancement in estimating kidney function. By refining the relationship between serum creatinine, demographics, and kidney filtration it offers a more accurate and clinically useful eGFR estimate across the full spectrum of kidney health. This precision enhances the detection and management of chronic kidney disease, ultimately improving patient outcomes. As clinical practice evolves, CKD-EPI is becoming the preferred standard for eGFR calculation in many healthcare settings.
What is the Estimated Glomerular Filtration Rate (eGFR)?
Estimated Glomerular Filtration Rate (eGFR) is a calculated approximation of the glomerular filtration rate (GFR), which measures how effectively the kidneys filter blood. The GFR represents the volume of blood filtered by the kidneys' glomeruli—small capillary networks within the nephrons—per minute. Since direct measurement of GFR is complex and invasive, eGFR provides a practical, non-invasive way to assess kidney function, detect kidney disease early, and monitor its progression in clinical practice.
eGFR is calculated using mathematical equations that incorporate serum creatinine levels along with patient-specific factors such as age, sex, race/ethnicity, and sometimes body size. Creatinine is a waste product generated by muscle metabolism and is normally removed from the blood by the kidneys. When kidney function declines, creatinine clearance decreases, causing serum creatinine levels to rise. This relationship allows serum creatinine to serve as an indirect marker of kidney filtration efficiency.
The two most commonly used equations to estimate GFR are:
Modification of Diet in Renal Disease (MDRD) Formula: This equation includes variables such as serum creatinine, age, sex, race, and additional factors like serum albumin and blood urea nitrogen in its clinical version. It tends to be more accurate in patients with moderate to severe kidney disease but may underestimate GFR in people with normal or mildly impaired kidney function.
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Equation: Developed to improve accuracy, especially at higher GFR values, the CKD-EPI equation uses serum creatinine, age, sex, and race. It is now recommended as the preferred method for estimating GFR in many clinical settings.
The eGFR is expressed in milliliters per minute per 1.73 square meters (mL/min/1.73 m²), which standardizes kidney function relative to an average adult body surface area. This standardization facilitates comparisons across individuals of different sizes.
Clinicians use eGFR values to classify chronic kidney disease (CKD) into stages, ranging from Stage 1 (normal or high GFR but with evidence of kidney damage) to Stage 5 (end-stage kidney disease requiring dialysis or transplantation). Regular eGFR monitoring helps track the progression of CKD, guides treatment decisions, and informs prognosis. It also assists in dosing medications that are cleared by the kidneys and in planning for renal replacement therapy when necessary.
While eGFR is a valuable clinical tool, it has limitations. Factors such as extreme muscle mass, diet, certain medications, and acute changes in kidney function can affect serum creatinine levels and thus the accuracy of eGFR. In such cases, alternative markers like cystatin C or direct GFR measurement methods may be considered.
Diagnostic Applications of Measuring GFR
Glomerular Filtration Rate (GFR) measurement plays a crucial role across a broad range of diagnostic settings, from evaluating kidney function in apparently healthy individuals to managing patients with acute or chronic kidney disease. Its primary diagnostic applications include:
1. Diagnosis of Chronic Kidney Disease (CKD)
One of the key clinical uses of GFR is in diagnosing chronic kidney disease, a progressive condition characterized by a gradual decline in kidney function over months or years. A persistently reduced GFR—typically below 60 mL/min/1.73 m² sustained for at least three months—is a hallmark diagnostic criterion for CKD. Measuring eGFR allows healthcare providers to detect kidney impairment early, often before symptoms appear, enabling timely interventions that may slow disease progression and reduce the risk of complications.
2. Monitoring Disease Progression
For patients with established kidney disease, regular monitoring of GFR helps track the progression of the disease. A declining GFR indicates worsening kidney function, which may necessitate adjustments in treatment, such as changes in medication, dietary restrictions, or preparation for dialysis. Monitoring GFR is essential for preventing complications like fluid overload, electrolyte imbalances, and toxic build-up of waste products in the body.
3. Assessing Acute Kidney Injury (AKI)
In cases of acute kidney injury (AKI), where there is a sudden loss of kidney function, GFR can be used to assess the severity of the condition. AKI can occur due to factors such as dehydration, sepsis, medications, or trauma. By measuring serum creatinine and estimating GFR, healthcare providers can determine the extent of kidney damage and guide treatment decisions aimed at restoring kidney function.
4. Guiding Medication Dosing
Many medications are excreted by the kidneys, and impaired kidney function can lead to the accumulation of these drugs, potentially causing toxicity. GFR is used to guide medication dosing, particularly for drugs that are primarily cleared by the kidneys, such as antibiotics (e.g., vancomycin, aminoglycosides), chemotherapeutic agents, and certain blood pressure medications. For example, individuals with a low GFR may require reduced dosages or alternative medications to avoid adverse effects.
5. Pre-Transplant Evaluation
In the context of kidney transplantation, accurate GFR measurement is critical for assessing both potential donors and recipients. For kidney donors, GFR helps ensure that their remaining kidneys will have sufficient function post-donation. For recipients, GFR is used to determine eligibility for transplantation and assess the success of the transplant over time.
6. Screening for Kidney Damage in High-Risk Populations
Certain groups are predisposed to kidney disease, including those with diabetes mellitus, hypertension, cardiovascular disease, obesity, or a family history of renal disorders. Routine eGFR screening in these populations facilitates early identification of kidney dysfunction before clinical symptoms arise. Early detection enables interventions such as tight blood glucose and blood pressure control, lifestyle modifications, and avoidance of nephrotoxins, which collectively slow disease progression and improve long-term outcomes.
Factors Influencing GFR Measurement
While GFR is a vital tool for assessing kidney function, several factors can influence the accuracy and interpretation of GFR measurements, particularly when using estimated GFR (eGFR) formulas:
Age
GFR naturally declines with aging, even in otherwise healthy individuals. This age-related decline means that lower GFR values in older adults may be normal and not necessarily indicative of kidney disease. It is important to consider age-related changes when interpreting GFR to avoid overdiagnosing renal impairment in the elderly.
Muscle Mass
Serum creatinine, a key variable in estimating GFR, is a byproduct of muscle metabolism. Therefore, individuals with greater muscle mass—such as athletes or bodybuilders—often have higher baseline serum creatinine levels, which may lead to an underestimation of their true GFR. Conversely, people with reduced muscle mass, including the elderly, malnourished individuals, or those with muscle-wasting diseases, may have lower serum creatinine, potentially causing an overestimation of GFR. This limitation is one reason why creatinine-based estimates can be less accurate in certain populations.
Sex and Ethnicity
Sex and ethnicity influence muscle mass and creatinine generation. GFR estimating equations such as the CKD-EPI and MDRD adjust for these factors to improve accuracy. For example, African American individuals generally have higher average muscle mass and creatinine production, leading the equations to include a correction factor to avoid underestimating their kidney function. Similarly, sex adjustments account for the typically lower muscle mass in females compared to males.
Diet and Medications
Dietary factors, especially high protein intake, can transiently raise serum creatinine levels, affecting GFR estimation. Some medications, such as trimethoprim or cimetidine, interfere with creatinine secretion by the kidneys, falsely elevating serum creatinine without an actual change in GFR. Dehydration can also concentrate serum creatinine, leading to underestimation of kidney function. These factors should be considered when interpreting eGFR results.
Summary
The glomerular filtration rate (GFR) is an important measure of kidney function and is used to diagnose and monitor a range of kidney diseases. GFR is typically measured using a blood test and a urine test, and it is calculated using a formula that takes into account the creatinine level in the blood, age, sex, and other factors.
The estimated glomerular filtration rate (eGFR) is a useful tool for monitoring kidney function and diagnosing kidney disease, as it provides an estimate of how well the kidneys are filtering waste products from the blood. It is important to monitor GFR and eGFR regularly in people with kidney disease to help guide treatment decisions and prevent complications.
References
Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N. and Roth, D., 1999. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Annals of Internal Medicine, 130(6), pp.461-470. https://doi.org/10.7326/0003-4819-130-6-199903160-00002
Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y.L., Castro, A.F., Feldman, H.I., Kusek, J.W., Eggers, P., Van Lente, F., Greene, T. and Coresh, J., 2009. A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150(9), pp.604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
KDIGO, 2012. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements, 3(1), pp.1–150. https://kdigo.org/guidelines/ckd-evaluation-and-management/
National Kidney Foundation, 2020. Estimating GFR (eGFR). [online] Available at: https://www.kidney.org/professionals/gfr_calculator [Accessed 20 May 2025].
